Genetic susceptibility to teratogens: state of the art.
There is evidence that the susceptibility to the teratogenic effect of drugs within human populations varies extremely from one individual to another, even after identical exposures. One of the factors that may explain these interindividual differences is the genetic makeup in the pharmacokinetics and pharmacodynamics of the respective drugs. In fact, both maternal and embryonic/fetal genotypes can affect placental transport, absorption, metabolism, distribution and receptor binding of an agent, influencing its teratogenicity. We have reviewed the literature and commented on the reported correlations between genetic factors and drug-induced birth defects. There is still a clear lack of knowledge regarding this issue and the available data are often conflicting. However, the identification of specific polymorphisms associated with predisposition to teratogenesis may allow in the future the development of personalized non-teratogenic therapies for pregnant women.
Teratology Information Service, Clinical Genetics Unit, Department of Woman and Child Health, University of Padova, Padova, Italy.
Matteo
M
Cassina
Leonardo
L
Salviati
Elena
E
Di Gianantonio
Maurizio
M
Clementi
D000014:Abnormalities, Drug-Induced / Q000235:genetics*; D000818:Animals; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D023421:Models, Animal; D011247:Pregnancy; D013723:Teratogens / Q000633:toxicity*
D013723:Teratogens